The Globe and Mail reports in its Tuesday, Aug. 1, edition that TD Cowen analyst Michael Tupholme has elevated his recommendation for Nutrien to "buy" from "hold." The Globe's Darcy Keith writes in the Eye On Equities column that Mr. Tupholme hiked his share target by $11 (U.S.) to $83 (U.S.). Analyst on average target the shares at $75.25 (U.S.). The Globe says Mr. Tupholme issued his upgrade even though the TD stockpicker believes the fertilizer company will soon reduce its 2023 earnings guidance. He says his decision, which comes before Nutrien reports earnings on Wednesday, reflects several considerations, including recent strength in crop and fertilizer price and attractive valuation. He thinks consensus earnings expectations have been pulled down since late 2022 and now have relatively limited downside. He notes that crop prices have exhibited strength in recent weeks, and appear likely to remain well-supported over the foreseeable future. He sees Nutrien's valuation as relatively attractive, particularly when viewed against a backdrop of potentially stronger crop and fertilizer prices. The Globe reported on May 9 that Mr. Tupholme maintained Nutrien at "hold." It was then worth $64.50 (U.S.).